Hospital Val d'Hebron

Barcelona 08035

0 studies enrolling now · 6 studies all time

What they study most

Chronic Lymphocytic Leukemia, Complicated Urinary Tract Infection (cUTI), Ewing's Osteosarcoma, Glioblastoma Multiforme, Gram-negative Bacterial Infections, Hematologic Neoplasms, Hospital Acquired Bacterial Pneumonia (HABP), Liver Cirrhosis, Multiple Myeloma, Neoplasm Metastasis, Non-alcoholic Fatty Liver Disease, Prostate Cancer

Studies at this site

• A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma — Running, not enrolling
• Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer — Completed
• A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participants — Completed
• Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis — Stopped early
• Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies. — Completed
• A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers — Completed